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Summary
Background and objectives Radiographic calcification and arterial stiffness each individually are predictive
of outcome in dialysis patients. However, it is unknown whether combined assessment of these intermedi-
ate endpoints also provides additional predictive value.
Design, setting, participants, & measurements Scoring of abdominal aortic calcification (AAC) using plain
lateral abdominal x-ray and measurement of carotid-femoral pulse wave velocity (PWV) were performed in
a cohort of 1084 prevalent dialysis patients recruited from 47 European dialysis centers.
Results During a follow-up of 2 years, 234 deaths and 91 nonfatal cardiovascular (CV) events occurred.
Compared with the lowest tertile of AAC, the risk of an event was increased by a factor 3.7 in patients
with a score of 5 to 15 (middle tertile), and by a factor 8.6 in patients with scores of 16 to 24. Additionally,
each 1-m/s increase in PWV was associated with a 15% higher risk. At higher AAC (scores 5), the effect
of PWV was attenuated because of a negative PWV  AAC interaction (hazard ratio [HR]: 0.895 and 0.865
for middle and upper AAC tertiles). After accounting for age, diabetes, and serum albumin, AAC and PWV
remained independent predictors of outcome.
Conclusions AAC and central arterial stiffness are independent predictors of mortality and nonfatal CV
events in dialysis patients. The risk associated with an increased PWV is less pronounced at higher levels
of calcification. Assessment of AAC and PWV is feasible in a clinical setting and both may be used for an
accurate CV risk estimation in this heterogeneous population.
Clin J Am Soc Nephrol 6: 153–159, 2011. doi: 10.2215/CJN.05120610
Introduction
Over the past decade, vascular calcification and stiff-
ening of the central elastic-type arteries have been
shown to be independent predictors of cardiovascular
(CV) morbidity and mortality in patients with chronic
kidney disease on dialysis (1,2). Animal studies sug-
gest that disturbances of bone and mineral metabo-
lism play a major role in the initiation and progres-
sion of medial wall calcification (3,4), which in turn
may contribute to increased aortic stiffness. The pres-
sure wave speed is directly related to the elastic mod-
ulus of the arterial wall according to the Moens–
Korteweg equation, and carotid-femoral pulse wave
velocity (PWV) is considered the gold standard
method for assessing aortic stiffness (5). A high PWV
causes an earlier return of peripherally reflected pres-
sure waves, which increases the cardiac workload by
augmentation of the central pulse pressure.
The Calcification Outcome in Renal Disease (CORD)
study prospectively evaluated the predictive value of
abdominal aortic calcification (AAC), arterial stiffness
(PWV), and wave reflection for the occurrence of CV
events and mortality in dialysis patients. This multi-
center study was designed to reflect daily clinical prac-
tice and therefore used low-cost resources and widely
available methodology with a minimal burden for pa-
tients and physicians. The aim of the analysis presented
here was to evaluate whether radiographically mea-
sured aortic calcification and central PWV could pro-
vide additional complementary predictive value for all-




Patients aged 18 years or older and treated by main-
tenance hemodialysis (HD) or peritoneal dialysis (PD)
for at least 3 months were enrolled at 47 European
dialysis centers after selection by a computer algo-
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resentative sample of all prevalent patients screened
at the start of the study with regard to age, gender,
time on dialysis, diabetes, and smoking status. Exclu-
sion criteria were conditions making arterial measure-
ments technically impossible or unreliable (cardiac
arrhythmias, amputations, severe peripheral vascular
lesions) and a life expectancy of 6 months. The
ethics committee at each participating center ap-
proved the study and all patients gave written in-
formed consent.
Assessment of AAC and Arterial Stiffness
Calcification was assessed by semiquantitative
scoring of a plain lateral lumbar radiograph (AAC
scores) according to a previously validated method
(6). All radiographs were collected for central reading
and scored by two investigators (one for the Nordic
countries and one for Belgium and The Netherlands)
who were blinded to the patient data. Because opti-
mal cutoff values of AAC scores for predicting out-
come in dialysis patients were unknown, the scores
were categorized into tertiles, consistent with the ap-
proach used by Wilson and coworkers (7). In the
cohort presented here, this corresponded to scores of
4 (no or minor calcification), 5 to 15 (moderate cal-
cification), or 16 (heavy calcification).
Hemodynamic measurements were performed in
the supine position by trained research nurses, tech-
nicians, or study physicians and before a HD session
or after drainage of the abdominal cavity in PD pa-
tients. PWV was obtained by sequential recording of
electrocardiogram-gated carotid and femoral artery
pressure waves using applanation tonometry (Sphyg-
moCor version 7, AtCor Medical, Sydney, Australia).
The path length was calculated by subtracting the
distance between sternal notch and carotid recording
site from the distance between sternal notch and fem-
oral site. PWV was calculated as the path length di-
vided by transit time (m/s).
Follow-Up
Patients were followed prospectively for the occur-
rence of nonfatal CV events or death from any cause,
whichever came first. Nonfatal CV events were de-
fined as myocardial infarction, coronary revascular-
ization procedures, stroke, or transient ischemic at-
tack. When multiple events occurred in the same
patient, only the time to the first event was analyzed.
Statistical Analyses
Differences in risk factors between patients with
and without an event were tested using the 2 statistic
for discrete variables and the t test or the Wilcoxon
rank-sum test for continuous variables, depending on
the distribution. Kaplan–Meier cumulative-event
curves according to tertiles of AAC scores and PWV
were constructed to describe the frequency of events
according to time since baseline measurements and
compared by the Mantel (log-rank) test. HRs were
calculated using Cox proportional hazards models to
estimate the relationship of AAC scores and PWV
with outcome. PWV was analyzed as a continuous
variable and AAC scores in groups of tertiles. An
interaction was tested for AAC scores with PWV on
the basis of the prevailing hypothesis that calcification
contributes to arterial stiffness, thus potentially limit-
ing their ability to independently predict outcome at
higher levels of calcification. The statistical signifi-
cance of the interaction was estimated by means of the
likelihood-ratio test to assess the effect of removing
the interaction term. After forcing AAC score, PWV,
and age into the model, we allowed any of the fol-
lowing variables to enter the model in a stepwise
forward selection procedure based on the likelihood-
ratio test: gender, race, current smoking status, dia-
betes, dialysis modality (HD or PD), time on dialysis,
body mass index, mean arterial pressure, treatment
with an angiotensin converting enzyme inhibitor or
angiotensin receptor blocker, treatment with a statin,
treatment with phosphate binders (none, calcium-
containing or noncalcium containing) and serum lev-
els of hemoglobin, albumin, calcium corrected for
albumin, phosphate, calcium-phosphorus product,
ln(parathyroid hormone), ln(C-reactive protein), ln-
(triglycerides), total cholesterol, HDL cholesterol, and
LDL cholesterol.
We chose not to include history of CV disease as a
covariate in the stepwise statistical modeling proce-
dure because of several reasons: (1) the main interest
was not to establish an optimal mathematical predic-
tion model but to identify factors that may be causally
related to outcome and/or may be modified by treat-
ment; (2) history of CV disease is a crude dichoto-
mous measure that lacks any information on type and
number of events, as well as their time-relation to the
start of the study; (3) finally, the validity of a statisti-
cal model that includes a variable that is a predictor
and outcome measure at the same time may be ques-
tioned. Nevertheless, univariate (stratified) Kaplan–
Meier and multivariate Cox regression analyses were
repeated with CV disease history included to verify
the consistency of our conclusions. The validity of the
proportionality assumption was verified by analysis
of the scaled Schoenfeld residuals using S-PLUS, ver-
sion 6.1. The other statistical analyses were performed
with SPSS, version 15. All P values are two-tailed, and
95 percent confidence intervals were calculated.
Results
From January 1, 2004 to June 30, 2005, 1084 patients
were enrolled, of whom 17 (1.6%) had incomplete
data, leaving 1076 patients included in the analysis
presented here. After a median follow-up of 2 years,
234 deaths and 91 nonfatal CV events were recorded.
Details on numbers of events are displayed in Table 1.
Table 2 shows the hemodynamic parameters and
characteristics of patients with and without events.
Absolute 2-year risks according to the joint distribu-
tion of tertiles of AAC and PWV (Figure 1) indicate
that the additional prognostic value of one measure is
dependent of the level of the other. Unadjusted
Kaplan–Meier cumulative-event curves according to
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tertiles of AAC scores and PWV are displayed in
Figure 2. Differences among these curves were statis-
tically significant (P  0.001) for both measures.
Figure 3 displays the age-adjusted hazard ratios
(HRs) associated with higher tertiles of AAC scores
(Figure 3A) and PWV (Figure 3B). Table 3 shows the
independent effects of AAC scores and PWV accord-
ing to the Cox regression model, adjusted for age and
for the effect of diabetes and lower serum albumin as
additional significant covariates retained in the step-
wise regression procedure. Calcification had a major
effect with a8-fold increase in HR for AAC scores in
the highest compared with the lowest tertile. In addi-
tion, for each 1-m/s increase in PWV, the HR in-
creased by 1.15%. The effect of PWV was weaker in
the middle and upper tertiles of AAC scores com-
pared with the lowest tertile, as indicated by the
negative coefficients for the PWV by AAC score in-
teractions. Figure 4 illustrates the difference in sur-
vival between patients with a PWV 12 m/s versus a
PWV 8.8 m/s for patients with minimal and severe
calcification, indicating effect modification. The larg-
est difference in survival according to PWV is ob-
served in patients with an AAC score 5. Outcome
was not influenced by gender or race.
Including CV disease history in the univariate
(stratified) Kaplan–Meier and multivariate Cox re-
gression analyses only affected the estimated effect
size of calcification due to a high degree of collinearity
with AAC score, but it did not change the overall
conclusions (data not shown).
Discussion
Whereas calcification and PWV each individually
have been shown to be predictive of outcome, their
combined independent predictive value for the occur-
rence of CV events and mortality has never been
investigated. In the study presented here, it has been
shown that PWV retained its predictive value, inde-
pendent of the degree of calcification. The comple-
mentary prognostic information provided by these
simple investigations is of major importance for iden-
tifying subpopulations that may benefit from a spe-
cific intervention and for the design of future random-
ized trials in patients with chronic kidney disease.
Recent studies have demonstrated that brachial pulse
pressure, a proxy of arterial stiffness, is an important
parameter to take into account when deciding on
fluid removal and dry weight (8,9). For the manage-
ment of hyperphosphatemia, the choice of phosphate
binder (calcium- versus noncalcium-containing) may
be influenced by the degree of vascular calcification, if
the available data on the adverse effect of calcium
salts on the progression of vascular calcification and











Table 2. Baseline demographic characteristics and risk
factors according to outcome
No
Event Event P
Age (years) 59.2 68.1 0.001
Male gender (%) 59 62 0.526
Non-Caucasian (%) 6 3 0.143
Diabetes (%) 17 29 0.001











Hemoglobin (g/dl) 12.1 11.9 0.044
Albumin (g/L) 37.6 35.6 0.001
Calciumalb (mg/dl) 9.65 9.75 0.040
Phosphate (mg/dl) 5.27 5.04 0.027
Ca  P (mg2/dl2) 50.9 49.0 0.049






























Heart rate (min1) 72 72 0.416
AAC scorea 8 15 0.001
Calciumalb, calcium corrected for albumin; Ca  P,
calcium-phosphorus product; PTH, parathyroid
hormone.
aMedian value.
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outcome are confirmed (10–12). The detection of in-
creased values of these surrogate markers may also be
extremely valuable in apparently low-risk patients
and/or those enlisted for renal transplantation.
Therefore, calcification status and central arterial stiff-
ness should be considered for inclusion in routine
clinical practice to assess CV risk in dialysis patients.
Although calcification and stiffness had additive
prognostic value, their mutual contribution varied
according to the level of calcification: the risk associ-
ated with each 1-m/s increase in PWV was less pro-
nounced in patients with moderate to severe calcifi-
cation. This effect of modification of calcification
status on PWV could be because in heavily calcified
patients, calcium deposits will also be localized in the
medial layer of the vascular wall, thus contributing to
an increased stiffness. Conversely, patients without or
with only minor calcification still can have stiff arter-
ies because of other mechanisms, including an in-
creased collagen content in the vessel wall (13), accu-
mulation of advanced glycation end products in
diabetes (14), and endothelial dysfunction (15). An-
other explanation may be that PWV values are under-
estimated at higher levels of calcification because of
an inaccurate path length estimation because of aortic
tortuosity, a situation that could occur more fre-
quently in heavily calcified patients. However, in this
case, our conclusions regarding the importance of
combined measurement of PWV and AAC scores
would only be reinforced because a normal value of
one parameter does not exclude an increased value of
the other.
Our data confirm the results of earlier studies that
showed the independent predictive value of PWV (2)
and arterial calcifications (12,16) for outcome in dial-
ysis patients. However, the cohort presented here was
approximately 4 times larger and included HD and
PD patients, which allowed for the extrapolation of
the findings to the average European dialysis popu-
lation. As in the milestone paper on the effect of PWV
on survival (2), in the study presented here the pre-
dictive value of PWV was also independent of age
and serum albumin. In contrast, we did not find a
significant independent effect of hemoglobin or dia-
stolic blood pressure. This may be due to several
factors. Our cohort is more recent than that of Blacher
et al., which started in 1987 (2). Consequently,
progress in dialysis care, pharmacologic treatment,
and medical care in general may have influenced the
relative importance of other risk factors. We had sup-
plementary information on calcification and used a
combined endpoint that also included nonfatal CV
events in addition to mortality. Finally, our popula-
tion was approximately 10 years older and included
more patients with diabetes, both independent risk
factors for outcome.
The dramatic increase in the risk of CV events or
death associated with calcification is in line with re-
Figure 1. | Two-year risk of death or nonfatal CV event accord-
ing to tertiles of PWV and AAC.
Figure 2. | Unadjusted Kaplan–Meier cumulative-event curves
for all-cause mortality and first nonfatal CV event according to
tertiles of (A) AAC scores and (B) PWV. The differences among
all curves were statistically significant (P  0.001).
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cent publications on the prognostic effect of coronary
artery calcification (CAC) (12,17). As for CAC scores,
event rates approximately doubled per tertile increase
in AAC score. However, in contrast to computed
tomography-based methods, which remain the gold
standard for quantification, a plain lateral lumbar
x-ray is far less expensive and readily available. More-
over, a recent study demonstrated that abdominal
x-ray scoring had a very good discriminatory value
compared with CAC scores, with an area under curve
of the receiver-operating characteristic 0.70 at each
CAC threshold (18). The prognostic value of aortic
calcification has been demonstrated previously in the
general population using the same technique (7). Re-
cently, CAC scores were shown to contribute to the
risk of coronary events over and above traditional risk
factors, independently of racial or ethnic group (19).
Similarly, in our study AAC scores remained predic-
tive of outcome even after accounting for age, diabe-
tes, and serum albumin as a typical risk factor in
dialysis populations.
Dialysis patients are an extremely heterogeneous
population and subject to continuous changes in di-
alysis practice patterns and transplantation, which
may be one of the reasons why interventional trials
have so far been disappointing. Therefore, we should
probably focus our efforts on subgroups that actually
may benefit from interventions. The CORD study is
the first to implement in daily clinical practice two
simple and inexpensive tools that have complemen-
tary value in predicting risk.
The study presented here has some limitations. We
studied prevalent patients in a European dialysis
population. Therefore, one should be cautious in ex-
trapolating the results to incident patients or to non-
European dialysis populations who include more
non-Caucasian ethnic groups and/or have other risk
factor profiles as shown in the Dialysis Outcomes and
Practice Pattern Study (20). The follow-up period of 2
years was relatively short. However, many patients
included and the high event rates compensated for
this. Despite the stratified inclusion software algo-
Figure 3. | Age-adjusted HRs associated with higher tertiles of (A) AAC scores and (B) PWV.
Table 3. Final Cox regression model of factors predicting outcome
Variable HR 95% Confidence Interval P
Age (years) 1.024 1.013 to 1.035 0.001
Presence of diabetes 1.682 1.279 to 2.213 0.001
Serum albumin (g/L) 0.944 0.919 to 0.969 0.001
AAC score (tertile 1)a 1
AAC score (tertile 2) 3.682 1.356 to 9.997 0.011
AAC score (tertile 3) 8.640 3.528 to 21.158 0.001
PWV (m/s) 1.154 1.085 to 1.228 0.001
PWV  AAC score (tertile 1)a 1
PWV  AAC score (tertile 2) 0.895 0.828 to 0.968 0.005
PWV  AAC score (tertile 3) 0.865 0.808 to 0.925 0.001
aThe first tertile of AAC score and its interaction term PWV  AAC score (tertile 1) served as the reference group.
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rithm, the selection of patients might have been some-
what biased by the preference of the recruiting phy-
sician. Such a favorable selection bias would imply
that the actual risks are underestimated. Finally, this
was an observational study so that treatment effects
could not be evaluated. The strength of the CORD
study is that it is the first to demonstrate in a multi-
center trial that combined measurement of aortic cal-
cification and central arterial stiffness is feasible in
routine daily clinical practice and strongly predicts
adverse outcome.
Conclusions and Perspectives
AAC scores and carotid-femoral PWV provide mu-
tually independent predictive information for the oc-
currence of CV events and mortality in patients
treated with HD or PD and may help to identify
patients at high risk. These measures can be obtained
rapidly, cause little discomfort to the patient, are in-
expensive, and have the potential for a wide availabil-
ity, which makes them ideal candidates for imple-
mentation in daily clinical practice. Hopefully,
targeted interventions with a favorable effect on these
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